Fox Hill Wealth Management Sells 511 Shares of DaVita Inc. (NYSE:DVA)

Fox Hill Wealth Management trimmed its stake in shares of DaVita Inc. (NYSE:DVA) by 3.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 15,336 shares of the company’s stock after selling 511 shares during the quarter. DaVita comprises about 1.3% of Fox Hill Wealth Management’s portfolio, making the stock its 25th biggest holding. Fox Hill Wealth Management’s holdings in DaVita were worth $2,293,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of DVA. MML Investors Services LLC boosted its position in shares of DaVita by 1.3% during the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after purchasing an additional 68 shares in the last quarter. Exchange Traded Concepts LLC boosted its position in shares of DaVita by 8.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after purchasing an additional 68 shares in the last quarter. Impact Partnership Wealth LLC boosted its position in shares of DaVita by 3.7% during the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after purchasing an additional 70 shares in the last quarter. Contravisory Investment Management Inc. boosted its position in shares of DaVita by 1.2% during the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after purchasing an additional 73 shares in the last quarter. Finally, Nilsine Partners LLC boosted its position in shares of DaVita by 0.8% during the 4th quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock valued at $1,669,000 after purchasing an additional 92 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Up 0.0 %

Shares of NYSE:DVA opened at $149.27 on Wednesday. The firm has a market cap of $11.94 billion, a P/E ratio of 13.90, a PEG ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60. The business’s 50 day simple moving average is $158.80 and its two-hundred day simple moving average is $157.61. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, research analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on DVA shares. Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Barclays upped their target price on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on DaVita in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.